INTEGRA Biosciences believes that scientists deserve the tools to make their lives in the lab easier, faster and more productive, whether they’re carrying out serial dilutions, reformatting plates or transferring samples.

High quality glassware is essential to reliable and accurate laboratory results, and requires appropriate reprocessing to ensure continued performance and a long service life.

Under the agreement IONTAS will use its proprietary antibody discovery platforms to deliver antibodies against biological targets selected by LG Chem, Ltd. and to further prove the biological activity of the antibodies.

Robust Thermo Scientific TSQ Fortis Triple Quadrupole mass spectrometer designed for productivity across all levels of users.

Industry-leading adapters mitigate index hopping and spread of signal in
next gen sequencing applications.

Methods to monitor and potentially modulate the systemic response to cancer, offer new avenues for early detection, personalized medicine and therapeutic modalities.

Ram Group aims to introduce revolutionary low-cost point-of-care diagnostics and healthcare monitoring devices to low-income communities.

Collaboration enables high yield, high purity supercoiled plasmid DNA manufacture for therapeutic application.

Two additional licenses granted; upfront payment of US$18 million; total potential transaction value of up to US$484.7 million.

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announce that Unicancer, a hospital group entirely devoted to fighting cancer, has selected the MammaPrint® Breast Cancer Risk of Recurrence test and BluePrint® Molecular Subtyping test for use in its 18 French Comprehensive Cancer Centers (FCCC).